Lung Injury: Clinical Trials

33 trials for Lung Injury, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed, 10 unknown, 2 not yet recruiting, 2 recruiting. 33 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 433Completed 18, Unknown 10, Not yet recruiting 2, Recruiting 2, Terminated 1

Follow Lung Injury: new trials by email Literature Review of Lung Injury trials Research Report on Lung Injury

Trials (filtered) newest first · largest first

All 33 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of Higher Zinc Supplementation on Neonatal Weight Velocity
1 mg/day Zinc Supplementation, 3 mg/day Zinc Supplementation - Extreme Prematurity,Extremely Low Birthweight, BPD - Bronchopulmonary Dysplasia
Phase 4RecruitingAugusta University302026-08-012026-10-26
Perioperative Lidocaine for Lung Protection in Infants Undergoing Cardiac Surgery
Lidocaine %2 ampoule, Normal Saline (0.9% NaCl) - Congenital Heart Disease, Postoperative Pulmonary Complications
Phase 4Not yet recruitingThe Children's Hospital of Zhejiang University School of Medicine3202026-04-012026-03-30
Ciprofol's Impact on Oxygenator Function in Extracorporeal Membrane Oxygenation (ECMO) Patients
Ciprofol, Midazolam - ECMO Treatment, ARDS (Acute Respiratory Distress Syndrome)
Phase 4Not yet recruitingFirst Affiliated Hospital of Wannan Medical College302025-05-012025-04-18
Enteral Lipid Supplementation and Bronchoplumonary Dysplasia of Premature Infants
Enteral supplementation with ARA and DHA (in a 2:1 ratio) in addition to standard care and feeding, Standard care and feeding - Bronchopulmonary Dysplasia (BPD)
Phase 4RecruitingAristotle University Of Thessaloniki742025-03-042026-06-17
Efficacy of Intrathecal Administration of Budesonide to Prevent Bronchopulmonary Dysplasia
Experimental - Bronchopulmonary Dysplasia (BPD)
Phase 4CompletedUniversitas Indonesia862024-11-012026-07-24
THE EFFECT OF NEBULIZED AZITHROMYCIN AS THERAPY FOR BRONCHOPULMONARY DYSPLASIA
Azithromycin neubilization, Lung ultrasound - Bronchopulmonary Dysplasia, Premature
Phase 4CompletedAlexandria University1002024-10-022025-07-20
Pragmatic Research on Diuretic Management in Early BPD Pilot
Furosemide (plus potassium chloride), Placebo (plus placebo electrolyte solution) - Bronchopulmonary Dysplasia
Phase 4CompletedChildren's Hospital Medical Center, Cincinnati192023-08-172026-07-14
The Caffeine Therapy in the Fetal to Neonatal Transition
Early Caffeine administration, Control Group - Mechanical Ventilation Complication, Caffeine
Phase 4UnknownHospital de Clinicas de Porto Alegre502022-04-272025-04-02
Continuous Infusion Versus Intermittent Boluses of Cisatracurium in the Early Management of Pediatric ARDS
Intermittent boluses of Cisatracurium, Intravenous infusion of Cisatracurium for 24 hours - Respiratory Distress Syndrome, Pediatric, Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
Phase 4UnknownTanta University602022-01-062022-06-22
The Efect of Azithromicyn on Bronchopulmonary Displasia in Extremely Preterm and Very Preterm Infant
Azithromycin Powder - Bronchopulmonary Dysplasia, Intraventricular Hemorrhage
Phase 4CompletedUniversitas Indonesia1202021-06-082024-03-08
Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury
Heparin, 0.9% Sodium-chloride - Covid-19, ARDS, Human
Phase 4TerminatedFrederick Health132020-06-012024-04-03
Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)
Sargramostim, Control - COVID-19
Phase 4CompletedUniversity Hospital, Ghent872020-03-242022-11-16
Intra-tracheal Instillation of Budesonide to Prevent Chronic Lung Disease
Infants in the study group (S/B group) will receive surfactant 2.5 mls/kg and Budesonide 0.5 mg (1mL), Infants in the control group (S/P group) receive placebo (Normal saline 1mL) - Infant, Extremely Premature, Acute Lung Injury
Phase 4UnknownUniversity of Arizona252019-12-022022-11-01
Zinc Supplementation on Very Low Birth Weight Infant
Zinc Sulfate, Placebos - Early-Onset Sepses, Neonatal, Periventricular Haemorrhage Neonatal
Phase 4UnknownFakultas Kedokteran Universitas Indonesia3642019-08-202019-08-15
Intratracheal Budesonide/Surfactant Prevents BPD
budesonide, Saline - Respiratory Distress Syndrome, Bronchopulmonary Dysplasia
Phase 4CompletedTaipei Medical University3102019-07-012023-05-30
Impact of Lidocaine Administration on Postoperative Complications During Lung Resection Surgery
Lidocaine, Remifentanil - Lung Diseases, Lung Inflammation
Phase 4CompletedFrancisco Andres de la Gala1562019-01-282021-08-25
Oxygenation Targets in Cardiac Surgery Patients - a Before-and-after Study
Oxygen - Hyperoxia, Cardiac Surgery
Phase 4UnknownAalborg University Hospital502018-10-012019-10-28
Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.
Budesonide, Poractant Alfa, Saline - Bronchopulmonary Dysplasia, Infant,Premature
Phase 4UnknownHospital Central "Dr. Ignacio Morones Prieto"1082018-01-012019-08-07
Early Caffeine in Preterm Neonates
Caffeine Citrate, Placebo (Normal Saline) - BPD - Bronchopulmonary Dysplasia, Apnea of Prematurity
Phase 4UnknownJennifer Shepherd242017-02-012021-08-03
Effects of SEvoflurane on Gas Exchange and Inflammation in Patients With ARDS (SEGA Study)
sevoflurane, midazolam - Acute Respiratory Distress Syndrome
Phase 4CompletedUniversity Hospital, Clermont-Ferrand502014-04-012026-04-21

Showing 20 of 33. Sign in to see all of them.

Narrower conditions

Bronchopulmonary Dysplasia (19)  ·  Acute Lung Injury (12)  ·  Respiratory Distress Syndrome (8)  ·  Premature Birth (5)  ·  COVID-19 (2)  ·  Enterocolitis, Necrotizing (2)  ·  Hypoxia (2)  ·  Lung Diseases (2)  ·  Meconium Aspiration Syndrome (2)  ·  Respiratory Aspiration (2)  ·  Apnea (1)  ·  Critical Illness (1)  ·  Disease (1)  ·  Dyspnea (1)

Broader conditions

Respiratory Tract Diseases (32)  ·  Lung Diseases (31)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (22)  ·  Infant, Newborn, Diseases (21)  ·  Infant, Premature, Diseases (18)  ·  Ventilator-Induced Lung Injury (18)  ·  Pathological Conditions, Signs and Symptoms (15)  ·  Respiration Disorders (13)  ·  Pathologic Processes (10)  ·  Female Urogenital Diseases and Pregnancy Complications (7)  ·  Pregnancy Complications (7)  ·  Urogenital Diseases (7)  ·  Obstetric Labor Complications (5)  ·  Obstetric Labor, Premature (5)

Interventions

Budesonide (4)  ·  Saline Solution (4)  ·  Midazolam (3)  ·  Sodium Chloride (3)  ·  poractant alfa (3)  ·  Air (2)  ·  Surface-Active Agents (2)  ·  (2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol (1)  ·  Albuterol (1)  ·  Azithromycin (1)  ·  Bronchoalveolar Lavage (1)  ·  Control Groups (1)  ·  Dexmedetomidine (1)  ·  Fentanyl (1)  ·  Fundoplication (1)

Sponsors

Hospital de Clinicas de Porto Alegre (2)  ·  Universitas Indonesia (2)  ·  University Hospital, Clermont-Ferrand (2)  ·  University of Arizona (2)  ·  Zekai Tahir Burak Women's Health Research and Education Hospital (2)  ·  Aalborg University Hospital (1)  ·  Alexandria University (1)  ·  Aristotle University Of Thessaloniki (1)  ·  Augusta University (1)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  China Medical University, China (1)  ·  Fakultas Kedokteran Universitas Indonesia (1)  ·  First Affiliated Hospital of Wannan Medical College (1)  ·  Francisco Andres de la Gala (1)  ·  Frederick Health (1)

Countries

United States (10)  ·  France (3)  ·  Turkey (Türkiye) (3)  ·  China (2)  ·  Egypt (2)  ·  Indonesia (2)  ·  Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Denmark (1)  ·  Greece (1)  ·  India (1)  ·  Israel (1)  ·  Japan (1)  ·  Mexico (1)

Top investigators

Adhi Teguh Perma Iskandar, Dr. dr. Sp. A(K) (1)  ·  Amanda Kim, MD (1)  ·  Anna Maria Hibbs, MD, MSCE (1)  ·  Bart Lambrecht (1)  ·  Bodil S Rasmussen, MD (1)  ·  Cynthia McEvoy, MD, MCR (1)  ·  Evelyn Phangkawira, dr. Sp. A (1)  ·  Francisco de la Gala, MD PhD (1)  ·  Heather Kaplan, MD, MSCE (1)  ·  Henri Azis, Master (1)  ·  James R Miner, MD (1)  ·  Jayendra R Gohil, MD (1)  ·  Jennifer L Shepherd, MD (1)

Results publications

PMID 26351971, PMID 18426851, PMID 20084586, PMID 20138301, PMID 20426859, PMID 25164872, PMID 26053233, PMID 26850232, PMID 26928567, PMID 27611637, PMID 29193276, PMID 30690595, PMID 31694684, PMID 32503663, PMID 32559419, PMID 32894857, PMID 33502773, PMID 35244208, PMID 36459994, PMID 40897588

NIH funding

2009 (1), R01HL095748 (1), R34HL158586 (1)